Micro RNA as a Potential Biomarker for the Diagnosis of Neonatal Sepsis – A Review

Ravi, Vidhya; Subramanian, Kathir; Sivasubramaniam, Jayanthi; Devaraj, Danis Vijay; Ramanujam, Sujhithra Appan

doi:10.14260/jemds/2021/83

jemds

2021

DOI: 10.14260/jemds/2021/83

|View full text |Cite

Micro RNA as a Potential Biomarker for the Diagnosis of Neonatal Sepsis – A Review

Vidhya Ravi¹,

Kathir Subramanian²,

Jayanthi Sivasubramaniam³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis

El-Khazragy,

Mohamed,

Mostafa

et al. 2023

Diagnostic Microbiology and Infectious Disease

View full text Add to dashboard Cite

miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis

El-Khazragy,

Mohamed,

Mostafa

et al. 2023

Diagnostic Microbiology and Infectious Disease

View full text Add to dashboard Cite

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer

Ravichandran,

Kumar,

Das

et al. 2024

CCDT

View full text Add to dashboard Cite

Colorectal cancer is one of the most common cancer types worldwide. Since colorectal cancer takes time to develop, its incidence and mortality can be treated effectively if it is detected in its early stages. As a result, non-invasive or invasive biomarkers play an essential role in the early diagnosis of colorectal cancer. Many experimental studies have been carried out to assess genetic, epigenetic, or protein markers in feces, serum, and tissue. It may be possible to find biomarkers that will help with the diagnosis of colorectal cancer by identifying the genes, RNAs, and/or proteins indicative of cancer growth. Recent advancements in the molecular subtypes of colorectal cancer, DNA methylation, microRNAs, long noncoding RNAs, exosomes, and their involvement in colorectal cancer have led to the discovery of numerous new colorectal cancer biomarkers. In small-scale investigations, most biomarkers appear promising. However, large-scale clinical trials are required to validate their effectiveness before routine clinical implementation. Hence, this review focuses on small-scale investigations and results of big data analysis that may provide an overview of the biomarkers for the diagnosis, therapy, and prognosis of colorectal cancer.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Micro RNA as a Potential Biomarker for the Diagnosis of Neonatal Sepsis – A Review

Cited by 2 publications

References 23 publications

miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis

miRNAs: novel noninvasive biomarkers as diagnostic and prognostic tools in neonatal sepsis

An Updated Review on Molecular Biomarkers in Diagnosis and Therapy of Colorectal Cancer

Contact Info

Product

Resources

About